## DHI: D.R. Horton, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -4.4% below STRENGTH zone (3.0-6.0%); PEG 1.17 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($138.23)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. What to Expect From D.R. Horton's Q1 2026 Earnings Report**
- Source: FinancialContent | 20251222T101100 | Somewhat-Bullish | Relevance: 100%
- D.R. Horton, Inc. (DHI) is set to announce its fiscal Q1 2026 earnings on January 20th, with analysts projecting a 24.1% decline in EPS to $1.98. Despite underperforming the S&P 500, the company has received a "Moderate Buy" rating from Wall Street analysts, with a mean price target indicating an 11.8% potential upside. This optimism is fueled by a positive outlook for the U.S. housing market, characterized by expected lower mortgage rates and sustained demand.

**2. Surprising Results Boosted D.R. Horton (DHI) in Q3**
- Source: Insider Monkey | 20251224T130731 | Bullish | Relevance: 100%
- Meridian Funds highlighted D.R. Horton, Inc. (NYSE: DHI) in their third-quarter 2025 investor letter, noting the homebuilder's unexpected strong performance. The company's stock outperformed due to better-than-expected home closings, new orders, resilient gross margins, and reduced construction costs. Despite this, D.R. Horton is not among the 30 most popular stocks for hedge funds, with some investors believing AI stocks offer greater short-term return potential.

**3. What to expect from DR Horton's Q1 2026 earnings report**
- Source: MSN | 20251224T110803 | Neutral | Relevance: 100%
- This article discusses upcoming expectations for DR Horton's Q1 2026 earnings report. It likely covers analyst predictions, key financial metrics to watch, and potential impacts on the stock.

**4. Assenagon Asset Management S.A. Has $2.70 Million Stock Position in D.R. Horton, Inc. $DHI**
- Source: MarketBeat | 20251224T082823 | Neutral | Relevance: 100%
- Assenagon Asset Management S.A. significantly reduced its stake in D.R. Horton, Inc. (NYSE:DHI) by 95.9% in the third quarter, now holding 15,903 shares valued at approximately $2.70 million. Despite D.R. Horton missing Q3 EPS estimates, its revenue beat expectations, and the company increased its quarterly dividend to $0.45 per share, representing a 1.2% yield. Analysts currently hold a "Hold" rating on the stock with an average price target of $161.08.

**5. Voya Investment Management LLC Sells 18,181 Shares of D.R. Horton, Inc. $DHI**
- Source: MarketBeat | 20251222T125218 | Neutral | Relevance: 100%
- Voya Investment Management LLC reduced its stake in D.R. Horton, Inc. ($DHI) by 13.2% in the 3rd quarter, selling 18,181 shares and holding 119,112 shares valued at $20.19 million. Other institutional investors also adjusted their positions, with notable increases from Wellington Management Group LLP and Price T Rowe Associates Inc. MD. D.R. Horton recently announced an increased quarterly dividend and analysts anticipate a full-year EPS of 13.04.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Barclays | $132 | $110 | +20% |
| 2025-12-08 | Wells Fargo | $180 | $190 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Barclays | main | Equal-Weight |
| 2025-12-08 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($0.00M) |
| Sells | 14 ($0.73M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.3% (-0.9%)
- Capital World Invest: 10.4% (+159.8%)
- Blackrock Inc.: 10.2% (+1.1%)
- JPMORGAN CHASE & CO: 7.2% (+96.2%)
- State Street Corpora: 4.2% (-2.8%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-3.8% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.17 suggests fair value with growth premium. Forward P/E 10.8x attractive for 19% earnings growth. Balance sheet: strong liquidity (17.4x), low leverage (D/E 0.44), $2.4B free cash flow. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $42.8B |
| Beta | 1.38 |
| 52W Range | $110.44 - $184.55 |
| Short Interest | 5.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.17 |
| Forward P/E | 10.8 |
| Current P/E | 12.9 |
| YoY Growth | 18.5% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from -0.6% to -4.4% (-3.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.4pp (needs >3.0% for momentum thesis). Underperforming sector by 5.5pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.02x) but short-term weakness (below SMA20). MACD histogram bearish (-1.27), momentum weakening. RSI neutral at 42. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -4.42% (CS: 5) | Weak |
| RSI_14 | 42.4 | Neutral |
| MACD Histogram | -1.27 | Bearish |
| vs SMA20 | 0.951x | Below |
| vs SMA50 | 0.972x | Below |
| vs SMA200 | 1.023x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $146.61
- **Stop Loss:** $138.23 (5.7% risk)
- **Target:** $154.99 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 107
- **Position Value:** $15,687.27
- **Portfolio %:** 15.69%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-01-20 (Est: $1.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.29 | $3.04 | -7.7% |
| 2025Q2 | $2.87 | $3.36 | +16.9% |
| 2025Q1 | $2.65 | $2.58 | -2.7% |
| 2024Q4 | $2.37 | $2.61 | +10.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*